Knott David M Jr »

Bridgebio Pharma shares owned by Knott David M Jr

Quarter-by-quarter ownership of Bridgebio Pharma (BBIO) shares owned by Knott David M Jr from 13F filings

Historical chart of Knott David M Jr investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Knott David M Jr consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Knott David M Jr

Quarter filed Position value Share count Share price at filing
2023-09-30 $237k 9.0k 26.33
2022-09-30 $1.4M 143k 9.94
2022-06-30 $1.9M 213k 9.08
2022-03-31 $2.0M 201k 10.15

More positions owned by Knott David M Jr

Calumet Specialty Products Partners Common (CLMT)
Apollo Global Management Common (APO)
FTAI Aviation Common (FTAI)
Alphabet Inc-Cl C Common (GOOG)
DocGo Common (DCGO)
Midwest Holding Common
Ligand Pharmaceuticals Incorporated Common (LGND)
Ardelyx Common (ARDX)
Coliseum Acquisition Corp. Wts Common (MITAW)
OmniAb Common (OABI)
CALLS/Calumet Specialty Product @20 ex1/24 Common
Franklin BSP Realty Trust Common (FBRT)
Seagen Common
Pfizer Common (PFE)
Panagram BBB-B CLO ETF Common (CLOZ)

View all positions for Knott David M Jr

Top funds holding Bridgebio Pharma

Kohlberg Kravis Roberts & Co
Viking Global Investors
Vanguard Group
Aisling Capital Management
Laurion Capital Management
Cormorant Asset Management
Goldman Sachs Group
Lord, Abbett & Co
Frazier Life Sciences Management
Alliancebernstein
Perceptive Advisors
Citigroup
Wellington Management Company
Hillhouse Capital Advisors
Norges Bank Investment Management

View all funds holding Bridgebio Pharma